(Q71816302)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589604%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Results of a prospective randomized trial using DTIC and interferon as adjuvant therapy for stage I malignant melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589604%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

main subject

randomized experiment

1 reference

1

M. J. Kerin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589604

28 May 2024

author name string

P. Gillen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589604

28 May 2024

J. R. Monson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589604

28 May 2024

J. Wilkie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589604

28 May 2024

F. B. Keane

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589604

28 May 2024

W. A. Tanner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589604

28 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7589604

28 May 2024

publication date

1 October 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589604%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Surgical Oncology

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589604%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589604%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589604%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

548-550

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589604%20AND%20SRC:MED&resulttype=core&format=json

Individual treatment for malignant melanoma

21 October 2019

uses

randomized experiment

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2895%2997305-2

7 January 2021

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2895%2997305-2

7 January 2021

Predicting survival and recurrence in localized melanoma: a multivariate approach

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2895%2997305-2

7 January 2021

Phase II study of interferon alpha-2a and dacarbazine in advanced melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2895%2997305-2

7 January 2021

Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2895%2997305-2

7 January 2021

Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2895%2997305-2

7 January 2021

10.1016/S0748-7983(95)97305-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589604%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference